Using Data to Prevent Opioid Diversion Act of 2018
USA115th CongressS-2838| Senate
| Updated: 6/19/2018
Dianne Feinstein
Democratic Senator
California
Cosponsors (4)
Judiciary Committee
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Using Data to Prevent Opioid Diversion Act of 2018 This bill establishes a new requirement intended to help drug manufacturers and distributors identify and prevent suspicious orders of opioids and reduce rates of diversion. Specifically, the Drug Enforcement Administration must to use its automated data system—the Automated Reports and Consolidated Ordering System—to inform drug manufacturers and distributors about the quantity and type of opioids that are distributed to pharmacies and practitioners.
Suggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in Senate
Read twice and referred to the Committee on the Judiciary. (Sponsor introductory remarks on measure: CR S2680-2681)
Committee on the Judiciary. Ordered to be reported with an amendment favorably.
Committee on the Judiciary. Reported by Senator Grassley with an amendment in the nature of a substitute. Without written report.
Placed on Senate Legislative Calendar under General Orders. Calendar No. 476.
Crime and Law Enforcement
Business recordsCivil actions and liabilityCongressional oversightCriminal investigation, prosecution, interrogationCriminal justice information and recordsDrug trafficking and controlled substancesGovernment information and archivesHealth personnelLicensing and registrationsRetail and wholesale trades
Using Data to Prevent Opioid Diversion Act of 2018
USA115th CongressS-2838| Senate
| Updated: 6/19/2018
Using Data to Prevent Opioid Diversion Act of 2018 This bill establishes a new requirement intended to help drug manufacturers and distributors identify and prevent suspicious orders of opioids and reduce rates of diversion. Specifically, the Drug Enforcement Administration must to use its automated data system—the Automated Reports and Consolidated Ordering System—to inform drug manufacturers and distributors about the quantity and type of opioids that are distributed to pharmacies and practitioners.
Suggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in Senate
Read twice and referred to the Committee on the Judiciary. (Sponsor introductory remarks on measure: CR S2680-2681)
Committee on the Judiciary. Ordered to be reported with an amendment favorably.
Committee on the Judiciary. Reported by Senator Grassley with an amendment in the nature of a substitute. Without written report.
Placed on Senate Legislative Calendar under General Orders. Calendar No. 476.
Dianne Feinstein
Democratic Senator
California
Cosponsors (4)
Judiciary Committee
Crime and Law Enforcement
Related Bills
- HR 115-6779: To amend the Controlled Substances Act to require the Drug Enforcement Administration to report certain information on distribution of opioids, and for other purposes.
- HR 115-6491: To amend the Controlled Substances Act to require the Drug Enforcement Administration to report certain information on distribution of opioids to manufacturers and distributors to help identify, report, and stop suspicious orders of opioids and reduce diversion rates, and for other purposes.
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Business recordsCivil actions and liabilityCongressional oversightCriminal investigation, prosecution, interrogationCriminal justice information and recordsDrug trafficking and controlled substancesGovernment information and archivesHealth personnelLicensing and registrationsRetail and wholesale trades